prednisone has been researched along with Lung Adenocarcinoma in 9 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After about 3 months the brain metastases had almost complete response." | 5.62 | Organizing pneumonia in ALK+ lung adenocarcinoma treated with ceritinib: A case report and literature review. ( Chen, H; Guan, J; Li, X; Wu, W; Wu, Y; Zhang, J; Zhang, K, 2021) |
| "Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases SUMMARY Programmed cell death protein 1 (PD-1) and its ligand 1 (PD-L1) have been widely used in lung cancer treatment, but their immune-related adverse events (irAEs) require intensive attention." | 1.72 | [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases]. ( Cao, BS; Gu, YC; Liu, Y; Xie, C, 2022) |
| "After about 3 months the brain metastases had almost complete response." | 1.62 | Organizing pneumonia in ALK+ lung adenocarcinoma treated with ceritinib: A case report and literature review. ( Chen, H; Guan, J; Li, X; Wu, W; Wu, Y; Zhang, J; Zhang, K, 2021) |
| "We describe a case of cardiac tamponade in a patient with stage IV lung adenocarcinoma, with almost 100% expression of PDL-1, treated with pembrolizumab." | 1.51 | Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab. ( Khan, AM; Mehdi, S; Munir, A; Munshi, MK; Thalody, V, 2019) |
| "Immune-related pancreatitis is a rare type of nivolumab-induced irAE that shows no significant changes on radiologic imaging, except for a swollen pancreas on CT, and can be suppressed using high-dose prednisone." | 1.43 | Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report. ( Ikeuchi, K; Okuma, Y; Tabata, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, YC | 1 |
| Liu, Y | 1 |
| Xie, C | 1 |
| Cao, BS | 1 |
| Satoh, T | 1 |
| Arai, E | 1 |
| Kayano, H | 1 |
| Sakaguchi, H | 1 |
| Takahashi, N | 1 |
| Tsukasaki, K | 1 |
| Yasuda, M | 1 |
| Khan, AM | 1 |
| Munir, A | 1 |
| Thalody, V | 1 |
| Munshi, MK | 1 |
| Mehdi, S | 1 |
| Wu, Y | 1 |
| Chen, H | 1 |
| Guan, J | 1 |
| Zhang, K | 1 |
| Wu, W | 1 |
| Li, X | 1 |
| Zhang, J | 1 |
| Hamada, S | 1 |
| Fuseya, Y | 1 |
| Tsukino, M | 1 |
| Reed, VA | 1 |
| Rizvi, N | 1 |
| Izzedine, H | 1 |
| Escudier, B | 1 |
| Rouvier, P | 1 |
| Gueutin, V | 1 |
| Varga, A | 1 |
| Bahleda, R | 1 |
| Soria, JC | 1 |
| Genestreti, G | 1 |
| Di Battista, M | 1 |
| Trisolini, R | 1 |
| Denicolò, F | 1 |
| Valli, M | 1 |
| Lazzari-Agli, LA | 1 |
| Dalpiaz, G | 1 |
| De Biase, D | 1 |
| Bartolotti, M | 1 |
| Cavallo, G | 1 |
| Brandes, AA | 1 |
| Ikeuchi, K | 1 |
| Okuma, Y | 1 |
| Tabata, T | 1 |
1 review available for prednisone and Lung Adenocarcinoma
| Article | Year |
|---|---|
A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literature.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agen | 2015 |
8 other studies available for prednisone and Lung Adenocarcinoma
| Article | Year |
|---|---|
[Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Topics: Adenocarcinoma of Lung; Adrenocorticotropic Hormone; Aged; B7-H1 Antigen; Humans; Hydrocortisone; Hy | 2022 |
Pulmonary intravascular large B-cell lymphoma accompanying synchronous primary pulmonary adenocarcinoma and benign interstitial lesions.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxo | 2019 |
Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab.
Topics: Adenocarcinoma of Lung; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic | 2019 |
Organizing pneumonia in ALK+ lung adenocarcinoma treated with ceritinib: A case report and literature review.
Topics: Adenocarcinoma of Lung; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Biopsy; Brain Neoplasms; | 2021 |
Pembrolizumab-Induced Rhabdomyolysis With Myositis in a Patient With Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antine | 2018 |
Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemothe | 2019 |
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineopla | 2013 |
Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunol | 2016 |